Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

(

WISP-R

)

ITN Protocol #:

ITN029ST

Branded Name:

WISP-R

ClinicalTrials.Gov ID:

NCT00320606

Treatment Protocol #:

Immunosuppression withdrawal

Therapeutic Area:

Transplantation

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Data Manager

Rho Scientist

Study Personnel:

Protocol Chair

Sandy Feng, MD PhD sandy.feng@ucsfmedctr.org

Work:

415-353-8725

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Bryna Burrell bburrell@immunetolerance.org

Work:

240-235-6130

Protocol Chair

Sai Kanaparthi skanaparthi@immunetolerance.org

Work:

(240)235-6101

Protocol Chair

Peter Sayre psayre@immunetolerance.org

Work:

415-353-4423

Protocol Chair

Allison Priore allison.girouard@nih.gov

Work:

240-627-3550

Protocol Chair

Caroline Christman caroline_christman@rhoworld.com

Work:

(919) 595-6349

Protocol Chair

Katie Poole katie_poole@rhoworld.com

Work:

919-595-6472